A randomized controlled trial comparing repeat doses of 400 mcg sublingual to buccal misoprostol after mifepristone for termination of pregnancy 13–21 weeks

Autor:	R. Abrahamyan, Tamar Tsereteli, Erica Chong, Dilfuza Kurbanbekova, Ingrida Platais, Beverly Winikoff, Yi Ling Tan, C. Murtagh, Hillary Bracken, Selma Hajri, Tara Shochet, Rasha Dabash, E. Sfar, Chanda Karki, D. Sadikova, J. Bajracharya
Rok vydání:	2017
Předmět:	Pregnancy medicine.medical_specialty Obstetrics business.industry Obstetrics and Gynecology Buccal administration Mifepristone medicine.disease law.invention Reproductive Medicine Randomized controlled trial law medicine business Misoprostol medicine.drug
Zdroj:	Contraception. 95:515
ISSN:	0010-7824
DOI:	10.1016/j.contraception.2017.02.004
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cd50cd4ece5038fa0cdd6abd118b67e2 https://doi.org/10.1016/j.contraception.2017.02.004 Zobrazit plný text záznamu Full Text from ScienceDirect